Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Observational Study of People Living With HIV Treated With CD19-directed CAR T Cell
An observational study of people living with HIV treated with CD19-directed CAR T-cell therapy has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating tandem stem cell transplantation for Non-Hodgkin lymphoma is currently active but not recruiting, sponso…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL) [Phase 1]
Phase 1 dose-escalation and dose-expansion study to evaluate the safety of Azer-cel (PBCAR0191) in relapsed/refractory non-Hodgkin lymphoma …
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL [Phase 1]
Phase 1 trial evaluating EBV-specific cytotoxic T lymphocytes for advanced B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia has …
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study of NB02 (POSELTINIB) as monotherapy for relapsed/refractory non-Hodgkin lymphoma is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Expanded Access to Venetoclax
Expanded access to venetoclax is being offered for multiple hematologic cancers, including chronic lymphocytic leukemia, multiple myeloma, A…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Lifestyle Intervention of Food and Exercise for Lymphoma Survivors [NA]
A University of Miami-led clinical trial evaluating a lifestyle intervention involving diet and exercise for lymphoma survivors is currently…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Study Evaluating Safety, PK, and Efficacy of Tafasitamab and Parsaclisib in Participants With Relapsed/Refractory Non Hodgkin Lymphoma (R/R NHL) or Chronic Lymphocytic Leukemia (CLL) [Phase 1, Phase 2]
Phase 1/2 study evaluating the safety, pharmacokinetics, and efficacy of the combination of tafasitamab and parsaclisib in relapsed/refracto…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Study of AXT-1003 in Subjects With Advanced Malignant Tumors. [Phase 1]
Phase 1 clinical trial update for AXT-1003 in subjects with advanced malignant tumors. The study is currently recruiting for Non-Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers [Phase 1]
A Phase 1 safety study of PF-08046045/SGN-35T sponsored by Seagen has been terminated in adults with advanced lymphomas and Hodgkin disease.
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study evaluating safety, adverse events, changes in disease activity, and pharmacokinetics of intravenously infused ABBV-291 in adul…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: High-Dose vs Standard Ergocalciferol for Vitamin D Normalization in Aggressive Non-Hodgkin Lymphoma [NA]
This clinical trial compares high-dose versus standard-dose ergocalciferol to normalize vitamin D levels in patients with aggressive Non-Hod…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Clinical trial update describing a Bristol-Myers Squibb-sponsored study to perform transgene assay testing on tumor samples from patients wh…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases [Phase 2]
Phase 2 clinical trial evaluating a cord blood transplant using cyclophosphamide, fludarabine, and total-body irradiation in high-risk hemat…
-
FDA approval · 2026-01-16FDA Approved: ZYNLONTA — Supplemental Application (ADC Therapeutics America, Inc.)
The FDA approved a supplemental application for ZYNLONTA (loncastuximab tesirine) filed by ADC Therapeutics America, Inc., effectively updat…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study [EARLY_Phase 1]
Early-phase 1 pilot study investigating PET imaging of cancer patients with the radiopharmaceutical 124I-PUH71, with the trial status curren…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW) [NA]
The ARROW clinical trial, sponsored by Implenomics, is currently recruiting to study AYAHIV role-based responsibilities for an oncology-focu…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 1]
This is a Phase 1 trial evaluating anti-CD19 CAR-T cell therapy for relapsed or refractory non-Hodgkin lymphoma. The study is currently recr…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial assessing pembrolizumab with external beam radiation therapy in relapsed or refractory non-Hodgkin lymphoma; the study (NCT032…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
This clinical trial is currently recruiting a study on Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma, focusing on …
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies [Phase 1]
A Phase 1 clinical trial evaluating UB-VV111 with and without rapamycin for relapsed/refractory CD19+ B-cell malignancies is currently recru…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Evaluate the Safety of UF-KURE19 Cells in Non-Hodgkin Lymphomas [Phase 1]
Phase 1 trial update evaluating the safety of UF-KURE19 Cells in Non-Hodgkin lymphoma; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial evaluating palifermin in combination with leuprolide acetate to promote immune recovery after total body irradiation-…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
The document describes an ongoing clinical trial that collects peripheral blood or saliva samples for genetic epidemiology studies of famili…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 trial at Mayo Clinic evaluating low-dose selinexor in combination with choline salicylate for relapsed or refractory Hodgkin lymph…